A Part of the University of Maryland Medical Center

Connect with UMGCC
Facebook Twitter YouTube Blog iPhone
Email PageEmail page Print PagePrint page

Research Programs

Frontiers in Oncology Seminars

2013 - 2014 Frontiers in Oncology Seminars

The Frontiers in Oncology lecture series brings outstanding investigators involved in cancer research to the UMGCC campus each month. The series is designed to educate and provide exposure to the latest developments in cancer biology, treatment and diagnosis. It will be of interest to faculty members, oncologists, medical interns, nurses, pharmacologists, and research fellows.

When: 3rd Wednesday of every month, 8:00 a.m.
Where:

University of Maryland Health Science Facility II (HSF II) Auditorium
20 S. Penn Street, Baltimore, MD 21201

CME Credit: One (1)
Register online.
Contact:

410-328-7516
Note: If you would like to meet with the speaker, please contact Florence Wade.

2013-2014 Seminar Schedule
Drs. Dhan Kalvakolanu, Ph.D. (FIO Director); Donald Ayer (FIO speaker) and Kevin Cullen (Cancer Center Director)

September 18, 2013

Don Ayer, Ph.D.
Professor
Huntsman Cancer Institute
Department of Oncological Sciences
University of Utah
Salt Lake City, UT

Integrating Nutrient Sensing and Growth Control

October 9, 2013

Martin Carroll, M.D.
Associate Professor
Division of Hematology and Oncology
Philadelphia, PA 19104

Re-visiting the Acute Myeloid Leukemia Stem Cell Hypothesis

This seminar will be in room 600 of the HSF II building.
From left to right: Drs. Dhan Kalvakolanu, Ph.D. (FIO Director); David Gius (FIO speaker) and Kevin Cullen (Cancer Center Director)

November 20, 2013

David Gius, M.D., Ph.D.
Zell Family Scholar Professor
Department of Radiation Oncology
Feinberg School of Medicine
Northwestern University

Sirtuin-3: a Mitochondrial Mammary Suppressor SIRTainty

From left to right:  Drs. Curt Civin (sponsor); Suzanne Topalian (FIO speaker) and Dhan Kalvakolanu, Ph.D. (FIO Director)

December 18, 2013

Suzanne Topalian, M.D.,
Professor, Surgery and Oncology
Johns Hopkins University School of Medicine
Director, Melanoma Program, Kimmel Cancer Center
Baltimore, MD 21287

Immune Checkpoint Blockade: Mobilizing the Immune System to Treat Cancer

January 15, 2014 -- CANCELED

Laurence Cooper, M.D., Ph.D.
Grant Taylor, W.W. Sutow and Margaret Sullivan
Distinguished Professor of Pediatrics
Department of Pediatric Patient Care
The University of Texas MD Anderson Cancer Center
Houston, TX 77030

From left to right:  Michael Kastan (FIO speaker);  Feyruz Rassool (sponsor); and Kevin Cullen

February 19, 2014

Michael Kastan, M.D., Ph.D.
Executive Director, Duke Cancer Institute
William W. Shingleton Professor
Pharmacology and Cancer Biology
Duke University Medical Center
Durham, NC 27710

DNA Damage Responses: Bedside to Bench to Bedside

From left to right:  Drs. Kevin Cullen (Cancer Center Director); Davide Ruggero, Ph.D. Ronald Gartenhaus (sponsor); and Danilo Perrotti (Professor and Researcher in the Greenebaum Cancer Center)

March 19, 2014

Davide Ruggero, M.D.
Principal Investigator
Department of Urology
University of California, San Francisco
Helen Diller Family Cancer Research Building
San Francisco, CA 94158

Translating the Cancer Genome and Its Therapeutic Implications

From left to right: Drs. John Olson (sponsor); Angela Brodie (Cancer Center); Joyce Slingerland (speaker); Kevin Cullen (Cancer Center Director)

April 16, 2014

Joyce Slingerland, M.D.
Associate Director for Translational Research
Director, Braman Family Breast Cancer Institute
Breast Cancer Program Leader
UM Sylvester Comprehensive Cancer Center
Professor, Depts. of Medicine, Biochemistry & Molecular Biology
UM Miller School of Medicine
Miami, FL 33136

Links Between Oestrogen Receptor Activation and Proteolysis: Relevance to Hormone-Regulated Cancer Therapy

From left to right: Drs. Kevin Cullen (CC Director); Peter Sicinski (speaker); and Dhan Kalvakolanu  (FIO Activity Director)

May 21, 2014

Peter Sicinski, M.D., Ph.D.
Professor of Genetics
Department of Cancer Biology
Harvard Medical School
Dana-Farber Cancer Institute
Boston, NC 02115

Cell Cycle Machinery in Development and in Cancer

From left to right: Drs. Arnob Banerjee (sponsor); David A. Frank (speaker); Kevin Cullen (CC Director) and Dhan Kalvakolanu (FIO Activity Director)

June 18, 2014

David A. Frank, M.D., Ph.D.
Professor of Medicine
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215

STAT Signaling in the Pathogenesis and Treatment of Cancer



This page was last updated on: July 31, 2014.